Trial Profile
A first in human study investigating the pharmacokinetics, safety and efficacy of NS11821 in healthy male subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Mar 2017
Price :
$35
*
At a glance
- Drugs NS 11821 (Primary)
- Indications CNS disorders
- Focus Adverse reactions; First in man; Pharmacokinetics; Therapeutic Use
- 10 Mar 2017 New trial record